Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases
- 1st Edition - November 20, 2020
- Imprint: Academic Press
- Editors: Seyed Moayed Alavian, Seyed Mohammad Nabavi, Seyed Fazel Nabavi, Ana Teresa Sanches Silva
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 1 6 4 8 8 - 4
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 7 5 2 3 - 1
Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases provides evidence-based knowledge of the mechanism of action of natural compounds, as well as the… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteInfluence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases provides evidence-based knowledge of the mechanism of action of natural compounds, as well as the relation of structure and function of phytochemicals in hepatitis B and C, fatty liver disease, nonalcoholic fatty liver disease, liver cancer, biliary cirrhosis, and primary sclerosing cholangitis. The effect of phytochemicals in the hepatotoxicity of drugs is also addressed. Written for health professionals seeking reliable and up-to-date information on the beneficial or toxic effects of natural compounds on liver disease, this book is sure to be a welcomed resource for nutritionists, food chemists, natural product researchers, pharmacists, medical doctors, and pharmacognosists alike.
- Explores the benefits of phytonutrients, especially those with a wide spectrum of biological activities
- Addresses various liver diseases, including hepatitis B, hepatitis C, alcoholic fatty liver disease, nonalcoholic fatty liver disease, liver cancer, biliary cirrhosis, and primary sclerosing cholangitis
- Provides reliable, up-to-date information on the natural compounds that have protective or toxic effects on liver diseases
nutritionists, food chemists, natural product researchers, pharmacists, medical doctors, pharmacognosists, and gastroenterologists
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Contributors
- Preface
- Chapter 1: Introduction
- Abstract
- Part 1: Hepatoprotective Activity of Natural Compounds and Plant Extracts In Liver Diseases
- Chapter 2: Hepatitis B
- Abstract
- Acknowledgments
- Conflict of interest
- 2.1: Introduction
- 2.2: Rheum palmatum L.
- 2.3: Ganoderma lucidum (Curtis) P. Karst.
- 2.4: Oenanthe javanica (Blume) DC.
- 2.5: Curcuma longa L.
- 2.6: Phyllanthus amarus Schum. and Thonn.
- 2.7: Phyllanthus niruri L.
- 2.8: Swertia patens Burkill
- 2.9: Boehmeria nivea (L.) Gaudich.
- 2.10: Role of natural compounds in ameliorating hepatitis B
- 2.11: Conclusion
- Chapter 3: Hepatitis C
- Abstract
- Conflict of interest
- 3.1: Introduction
- 3.2: Etiology
- 3.3: Signs and symptoms
- 3.4: Genotypes and serotypes of HCV
- 3.5: Diagnosis (serology, biopsy, and screening)
- 3.6: Serology
- 3.7: Screening tests
- 3.8: Biopsy
- 3.9: Screening
- 3.10: Prevention
- 3.11: Treatment
- 3.12: Hepatoprotective activity of natural compounds and plant extracts in Hepatitis C
- 3.13: Conclusion
- Chapter 4: Alcoholic liver disease
- Abstract
- 4.1: Introduction
- 4.2: The cause and consequences of alcohol toxicity
- 4.3: Alcohol as a depressant
- 4.4: Complex treatment of alcohol disease
- 4.5: Conclusions
- Chapter 5: Hepatoprotective activity of natural compounds and plant extracts in nonalcoholic fatty liver disease
- Abstract
- Acknowledgments
- 5.1: Introduction
- 5.2: Nonalcoholic fatty liver disease pathogenesis and progression
- 5.3: Oxidative stress and lipotoxicity
- 5.4: Mediterranean diet and nonalcoholic fatty liver disease
- 5.5: Natural compound effects on nonalcoholic fatty liver disease
- 5.6: Conclusions
- Chapter 6: Liver cancer
- Abstract
- Conflict of interest
- 6.1: Introduction
- 6.2: Classification of hepatic cancers
- 6.3: Causes of liver cancer
- 6.4: Diagnosis
- 6.5: Conclusion
- Chapter 7: Chronic liver diseases
- Abstract
- 7.1: Introduction
- 7.2: Primary sclerosing cholangitis
- 7.3: Hepatic steatosis
- 7.4: Primary biliary cirrhosis
- 7.5: Liver fibrosis
- 7.6: The use of bioactive compounds and plant extracts in chronic liver diseases
- 7.7: Nutritional support in CLD
- Chapter 8: Drug-induced hepatotoxicity
- Abstract
- 8.1: Background
- 8.2: Hepatotoxicity: An overview
- 8.3: Drug metabolic pathways of the liver and hepatotoxicity
- 8.4: Drug-induced hepatotoxicity: Mechanisms and risk factors
- 8.5: Epidemiological aspects
- 8.6: Hepatoprotective activity of natural compounds and plant extracts in drug-induced hepatotoxicity
- 8.7: Conclusion
- Part 2: Influence of Nutrients, Plant Extracts and Natural Compounds In Liver Diseases
- Chapter 9: Influence of omega-3 fatty acids and monounsaturated fats in liver diseases
- Abstract
- Conflict of interest
- 9.1: Introduction
- 9.2: Chemistry and classification of omega fatty acids
- 9.3: Conversion of ALA to EPA and DHA
- 9.4: Chemistry and classification of MUFA
- 9.5: Sources of omega-3 fatty acids and MUFAs
- 9.6: Metabolism of omega-3 fatty acids and monounsaturated fats
- 9.7: Role of omega-3 fatty acids and monounsaturated fats in various liver diseases
- 9.8: Conclusion
- Chapter 10: Influence of vitamins (C, B3, D, and E) in liver health
- Abstract
- 10.1: Introduction
- 10.2: Vitamin C
- 10.3: Vitamin B3 (niacin)
- 10.4: Vitamin D
- 10.5: Vitamin E
- 10.6: Vitamin combinations and liver health
- 10.7: Conclusion
- Chapter 11: Influence of other nutrients (e.g., l-arginine, taurine, and choline) on liver diseases
- Abstract
- 11.1: Introduction
- 11.2: Liver diseases
- 11.3: Arginine
- 11.4: Taurine
- 11.5: Choline
- 11.6: Conclusions
- Chapter 12: Antioxidants with hepatoprotective activity
- Abstract
- 12.1: Introduction
- 12.2: Natural hepatoprotective agents
- 12.3: Synthetic hepatoprotectors with antioxidant activity
- 12.4: Conclusion
- Chapter 13: Plant extracts with putative hepatoprotective activity
- Abstract
- 13.1: Introduction
- 13.2: Conclusion
- Chapter 14: Plant extracts with putative hepatotoxicity activity
- Abstract
- Acknowledgments
- 14.1: Introduction
- 14.2: General concepts of hepatotoxicity
- 14.3: Hepatotoxicity induced by plant extracts and mushrooms
- 14.4: Conclusion
- Index
- Edition: 1
- Published: November 20, 2020
- Imprint: Academic Press
- No. of pages: 314
- Language: English
- Paperback ISBN: 9780128164884
- eBook ISBN: 9780128175231
SA
Seyed Moayed Alavian
Seyed Moayed Alavian is gastroenterologist and head of Tehran Hepatitis Center. He has authored/co-authored over 480 articles in local and international journals, including 300 articles indexed in ISI, 343 articles indexed in PubMed, and 55 articles indexed in Persian Journals and has more than 3800 citations to published articles as well as 65 books and booklets for physicians and patients.
Affiliations and expertise
Baqiyatallah University of Medical Sciences, Tehran, IranSN
Seyed Mohammad Nabavi
Seyed Mohammad Nabavi is a Biotechnologist and senior scientist in the Applied Biotechnology Research Centre, Baqiyatallah University of Medical Sciences, Tehran, Iran. His research interests are focused on natural products. Till now, he has authored/co-authored over 250 publications in international journals indexed in ISI and has more than 7000 citations to published articles and also more than 10 books.
Affiliations and expertise
Baqiyatallah University of Medical Sciences, Tehran, IranSN
Seyed Fazel Nabavi
Seyed Fazel Nabavi is a biotechnologist and Senior Scientist of Applied Biotechnology Research Center, Baqiyatallah University of Medical Science and a member of Iran’s National Elites Foundation. His research focused on the health-promotion effects of natural products. He is author/co-author of 170 publications in international journals, 45 communications at national and international congress and 4 chapters in book series. He is a referee of several international journals. He is also in the top 1% top scientists in the world in the fields of Agricultural Sciences and Pharmacology & Toxicology according to Essential Science Indicator from Thompson Reuters ISI.
Affiliations and expertise
Baqiyatallah University of Medical Sciences, Tehran, IranAS
Ana Teresa Sanches Silva
Ana Sanches Silva is a researcher at the National Institute of Agrarian and Veterinary Research (INIAV, IP). She obtained a degree in Pharmacy from the University of Coimbra, Portugal, and received her European Ph.D. in Pharmacy from the University of Santiago de Compostela, Spain, with honors. In addition, she was awarded with the prize for best doctorate student. Ana Sanches-Silva has a remarkable track record (over 100 scientific contributions in peer-reviewed journals or book chapters). She has more than 300 communications in national and international conferences. Her research interests are focused on the evaluation of safety and composition of food and food packaging. Moreover, her special interest is the study of food bioactive compounds and dietary supplements, and development of analytical methodologies for the analysis of bioactive compounds in food.
Affiliations and expertise
University of Coimbra, Coimbra, PortugalRead Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases on ScienceDirect